General description
Cisplatin is a platinum-based antineoplastic agent used to treat many types of cancer.
INN
Cisplatin
Medicine type
Chemical agent
EML status history
First added in 1984
(TRS
722)
for
Osteosarcoma of bone and articular cartilage of unspecified sites
Added in 1984
(TRS
722)
for
Malignant neoplasms of cervix uteri
Added in 1984
(TRS
722)
for
Germ cell tumour of testis
Added in 1984
(TRS
722)
for
Other specified malignant neoplasms of bronchus or lung
Added in 1984
(TRS
722)
for
Other specified malignant neoplasms of the ovary
Added in 1984
(TRS
722)
for
Malignant neoplasms of nasopharynx
Added in 1984
(TRS
722)
for
Squamous cell carcinoma of oropharynx
Added in 1984
(TRS
722)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Removed in 2009
(TRS
958)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
- Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL
Indications
Unspecified malignant neoplasms of ill-defined or unspecified sites
Other specified malignant neoplasms of the ovary
Germ cell tumour of testis
Osteosarcoma of bone and articular cartilage of unspecified sites
Other specified malignant neoplasms of bronchus or lung
Malignant neoplasms of nasopharynx
Malignant neoplasms of cervix uteri
Squamous cell carcinoma of oropharynx